HPC
IVVD icon

HM Payson & Co’s Invivyd IVVD Stock Holding History

HM Payson & Co’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-396
Closed -$594 – 1031
2022
Q4 		$594 Hold
396
– – ﹤0.01% 895
2022
Q3 		$1K Hold
396
– – ﹤0.01% 949
2022
Q2 		$1K Buy
396
+300
+313% +$941 ﹤0.01% 998
2022
Q1 		$0 Hold
96
– – ﹤0.01% 1098
2021
Q4 		$1K Buy
+96
New +$2.5K ﹤0.01% 1044

Other funds holding IVVD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

HM Payson & Co's IVVD Position: Q1 2023 in Review

HM Payson & Co sold out of Invivyd (IVVD) in Q1 2023, closing a stake of 396 shares — an estimated $594 sold.

HM Payson & Co first reported a position in IVVD in Q4 2021 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 70 funds tracked by Wall St. Rank hold IVVD as of Q1 2023.

  • HM Payson & Co reported no remaining Invivyd position as of Q1 2023 after selling out during the quarter.
  • HM Payson & Co sold 396 Invivyd shares in Q1 2023, an estimated $594.
  • HM Payson & Co first reported a position in Invivyd in Q4 2021 and held it in 5 quarters.
  • HM Payson & Co's Invivyd position peaked at $1K in Q3 2022.
  • 70 funds tracked by Wall St. Rank held Invivyd as of Q1 2023.

Based on HM Payson & Co's 13F filing for Q1 2023, filed 18 Apr 2023.